CARsgen Therapeutics Holdings Limited

HK$10.89As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2171Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (17.46%)
Div yield —
ROE (9.57%)
Biotechnology
Beta (5Y) 0.39
PE TTM —
TSR TTM (33.92%)
Mkt cap HK$6.123B
ROIC (12.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
4.38%
(69.56%)
Hold 9|11|4|6|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.13
0.13
5.14%
8.65%
18.19%
24.90%
Revenue¥M
485.8
501.2
515.0
500.5
(0.27%)
4.69%
5.63%
1.49%
Peers (US$781.0M)
Cap (US$)
PE
772.7M
—
780.5M
—
Capital
TTM
5Y
10Y
Leveragex
4.763
0.164
0.170
EBIT/Intx
2.431
0.303
0.284
Own earn%
87.29
(27.65)
(21.75)
Sh yield%
34.34
25.70
26.61
Owners
Insiders/Inst%
8.69
79.34
Short interest%
2.37
SBC / revenue%
0.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
8–16
$1 testx
0.0
Incr. ROIC%
1